Loratadine for the Prevention of G-CSF-related Bone Pain
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The research question for the current study is: Is loratadine more effective than placebo in
preventing G-CSF-related bone pain during autologous hematopoetic stem cell transplant in
patients with lymphoma or multiple myeloma? The hypothesis is that prophylaxis with
loratadine will help prevent or reduce the severity of bone pain in this setting.